As of May 2022 OPKO Health has a market cap of $2.39 Billion. This makes OPKO Health the world's 3311th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $2.38 B | -27.26% |
2021 | $3.27 B | 23.83% |
2020 | $2.64 B | 168.78% |
2019 | $0.98 B | -44.21% |
2018 | $1.76 B | -35.61% |
2017 | $2.74 B | -47.14% |
2016 | $5.18 B | -5.35% |
2015 | $5.47 B | 26.88% |
2014 | $4.31 B | 23.99% |
2013 | $3.48 B | 136.91% |
2012 | $1.46 B | 3.33% |
2011 | $1.42 B | 51.74% |
2010 | $0.93 B | 101.85% |
2009 | $0.46 B | 44.24% |
2008 | $0.32 B | -36.66% |
2007 | $0.50 B | 3419.37% |
2006 | $0.01 B | 108.71% |
2005 | $6.91 M | 25.42% |
2004 | $5.51 M | -60.92% |
2003 | $0.01 B | 149.22% |
2002 | $5.66 M | -89.49% |
2001 | $0.05 B |
On May 23rd, 2022 the market cap of OPKO Health was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $472.17 B | 19,644.51% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $201.41 B | 8,322.14% | ๐บ๐ธ USA |
![]() Regeneron Pharmaceuticals REGN | $74.90 B | 3,032.21% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $163.29 B | 6,728.47% | ๐บ๐ธ USA |
![]() LabCorp LH | $23.12 B | 867.14% | ๐บ๐ธ USA |
![]() Alnylam Pharmaceuticals
ALNY | $15.65 B | 554.63% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | $9.38 B | 292.33% | ๐ฎ๐ฑ Israel |
![]() Ardelyx ARDX | $0.09 B | -96.19% | ๐บ๐ธ USA |